ArticleJournal of translational medicine2014

PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche.

Elana Godebu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.